Sotera Health Director GTCR INVESTMENT XI LLC Sells 8M Shares at $15.11/Share.
ByAinvest
Tuesday, Sep 9, 2025 8:47 pm ET1min read
SHC--
The proceeds from the offering will not be received by the company itself, but rather will be used to cover the expenses related to the offering under the company's Amended and Restated Registration Rights Agreement. Goldman Sachs & Co. LLC is acting as the underwriter for the offering, and the securities have been registered with the Securities and Exchange Commission (SEC) [2].
Sotera Health, a leading global provider of end-to-end sterilization solutions and lab testing services, is committed to its mission of "Safeguarding Global Health." The company operates through three main businesses: Sterigenics®, Nordion®, and Nelson Labs®. The secondary offering is expected to help the company maintain its financial health and continue to support its growth initiatives [1].
This announcement comes at a time when the healthcare industry is experiencing significant growth, driven by increasing demand for sterilization services and lab testing solutions. Sotera Health's strong market position and commitment to innovation make it a key player in this sector.
References:
[1] https://seekingalpha.com/news/4492056-sotera-health-announces-secondary-offering-of-common-stock
[2] https://finance.yahoo.com/news/sotera-health-announces-secondary-offering-205700324.html
Sotera Health Co. [SHC] has recently disclosed that Director and 10% Owner GTCR Investment XI LLC has executed a transaction involving the sale of 8,000,000 shares at a price of $15.11 per share on September 5, 2025.
Sotera Health Company (NASDAQ: SHC) has announced a secondary offering of 20 million shares of its common stock, with a par value of $0.01 per share. The offering, which is set to take place on September 5, 2025, is being executed by certain affiliates of Warburg Pincus and GTCR as selling stockholders. Notably, GTCR Investment XI LLC, a 10% owner and director of the company, has agreed to sell 8 million shares at a price of $15.11 per share [2].The proceeds from the offering will not be received by the company itself, but rather will be used to cover the expenses related to the offering under the company's Amended and Restated Registration Rights Agreement. Goldman Sachs & Co. LLC is acting as the underwriter for the offering, and the securities have been registered with the Securities and Exchange Commission (SEC) [2].
Sotera Health, a leading global provider of end-to-end sterilization solutions and lab testing services, is committed to its mission of "Safeguarding Global Health." The company operates through three main businesses: Sterigenics®, Nordion®, and Nelson Labs®. The secondary offering is expected to help the company maintain its financial health and continue to support its growth initiatives [1].
This announcement comes at a time when the healthcare industry is experiencing significant growth, driven by increasing demand for sterilization services and lab testing solutions. Sotera Health's strong market position and commitment to innovation make it a key player in this sector.
References:
[1] https://seekingalpha.com/news/4492056-sotera-health-announces-secondary-offering-of-common-stock
[2] https://finance.yahoo.com/news/sotera-health-announces-secondary-offering-205700324.html

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue



Comments
No comments yet